IE
GNPX icon

Israel Englander’s Genprex GNPX Stock Holding History

Israel Englander’s Portfolio GNPX Stock Details GNPX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1
Closed -$6.49K – 6350
2023
Q4 		$6.49K Buy
+1
New +$11.5K ﹤0.01% 5786
2023
Q1 		– Sell
-1
Closed -$46K – 6541
2022
Q4 		$46K Sell
1
-2
-67% -$113K ﹤0.01% 5799
2022
Q3 		$203K Hold
3
– – ﹤0.01% 5652
2022
Q2 		$179K Sell
3
-2
-40% -$141K ﹤0.01% 5687
2022
Q1 		$485K Sell
5
-5
-50% -$488K ﹤0.01% 5148
2021
Q4 		$582K Buy
10
+3
+43% +$250K ﹤0.01% 4917
2021
Q3 		$870K Sell
7
-4
-36% -$518K ﹤0.01% 4833
2021
Q2 		$1.61M Buy
11
+8
+267% +$1.31M ﹤0.01% 4198
2021
Q1 		$547K Buy
+3
New +$659K ﹤0.01% 4751
2020
Q2 		– Sell
-1
Closed -$105K – 4311
2020
Q1 		$105K Buy
+1
New +$103K ﹤0.01% 3541

Other funds holding GNPX

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
NRG
Nemes Rush Group Novi, Michigan $1.21B AUM 33.22% 1-Year Est. Return

Israel Englander's GNPX Position: Q1 2024 in Review

Israel Englander sold out of Genprex (GNPX) in Q1 2024, closing a stake of 1 share — an estimated $6.49K sold.

Israel Englander first reported a position in GNPX in Q1 2020 and held it in 10 quarters. The position peaked at $1.61M in Q2 2021. 8 funds tracked by Wall St. Rank hold GNPX as of Q1 2024.

  • Israel Englander reported no remaining Genprex position as of Q1 2024 after selling out during the quarter.
  • Israel Englander sold 1 Genprex share in Q1 2024, an estimated $6.49K.
  • Israel Englander first reported a position in Genprex in Q1 2020 and held it in 10 quarters.
  • Israel Englander's Genprex position peaked at $1.61M in Q2 2021.
  • 8 funds tracked by Wall St. Rank held Genprex as of Q1 2024.

Based on Millennium Management's 13F filing for Q1 2024, filed 15 May 2024.